Search Results 2181-2190 of 16199 for Epilepsy (Partial Onset)

  1. Movement disorders - Doctors and departments - Mayo Clinic

    Jacksonville, FL. Areas of focus: Stroke, Brain tumor, Traumatic brain injury, Movement disorder, Dementia, Epilepsy ... early diagnosis of neurodegenerative ...

  2. A Study of Beta-Blockers for the Prevention of Acute Worsening of Chronic Obstructive Pulmonary Disease - Mayo Clinic

    During the early phases (phases 1 and 2), researchers assess safety, side ... duration of the study. Current tachy or brady arrhythmias requiring ...

  3. New directions in the study of Alzheimer's disease - Mayo Clinic News Network

    (VIDEO) When seizures don't stop: The battle against drug-resistant epilepsy. Neurosciences. Mayo Clinic contributes to national Alzheimer's disease research ...

  4. Publications - Bhavesh M. Patel, M.D. - Mayo Clinic

    Association of estimated plasma volume with new onset acute kidney injury in hospitalized COVID-19 patients. Am J Med Sci. 2024 Dec; 368 (6):589-599 Epub ...

  5. Endocrinology Clinical Trials - Medical Professionals

    Rochester, Minn. The primary purpose of this study is to determine pre-surgical and post-surgical predictors of the duration and severity of glucocorticoid ...

  6. Elapegademase-lvlr (intramuscular route) - Side effects & uses - Mayo Clinic

    seizures; severe pain in the side and back; shivering; sneezing; sore mouth or tongue; sore throat; stiff neck; stomach cramps and pain; sweating; swollen, ...

  7. Cardiovascular Research Center - Early Phase Clinical Trials Program

    Beginning setup with internal service areas. Stage 4: Study setup. In this final stage, our program team completes site activation in preparation for ...

  8. Myositis Interstitial Lung Disease Nintedanib Trial - Mayo Clinic

    ... duration <3 months) (50% vs 50%, p = 0.3862); while for subacute ILD patients (disease duration 3-6 months), the pirfenidone add-on (n = 10) had a ...

  9. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    About this study. The purpose of this study is to evaluate abdominal pain response to BOS-589 in participants with diarrhea-predominant Irritable Bowel ...

  10. Congenital Clinical Trials - Mayo Clinic Research

    The objectives of this study are to collect data on survival of pediatric patients with early onset of either GM1 gangliosidosis, GM2 gangliosidoses, or GD2 ...